SSO supports cancer research by providing research funding through its competitive Clinical Investigator and Young Investigator Awards programs. The SSO Clinical Investigator Award supports patient-focused research conducted by surgical oncologists in clinical and translational science. The SSO Young Investigator Award promotes and recognizes translational or clinical research that advances innovative ideas and concepts designed to improve health outcomes through advances in the delivery of cancer-related care. Funding for these awards is made possible by the SSO Research and Education Fund.
This year two Young Investigator Awards are available: one traditional award and one dedicated to a specific topic.
SSO is pleased to again offer a second, topic-specific SSO Young Investigator Award supported by a grant from the Appendix Cancer Pseudomyxoma Peritonei Research Foundation. Proposals related to appendix cancer, pseudomyxoma peritonei, peritoneal surface malignancies/peritoneal carcinomatosis (as related to appendix cancer and/or pseudomyxoma peritonei), and/or HIPEC as a treatment for appendix cancer/pseudomyxoma peritonei will be accepted.